Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced the ...

A company’s plan to edit the genomes of human embryos worries some researchers — but it might reflect the changing attitudes ...

Learn how labman is advancing biologics manufacturing through AI-powered bioreactor technology, driving innovation in drug ...

The Rising Wave of Esoteric Testing The Esoteric Testing Market represents a specialized segment of diagnostic laboratory services that focuses on rare and complex tests not routinely performed in ...